Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
AZITHROMYCIN DIHYDRATE
Pfizer Limited
J01FA10
AZITHROMYCIN DIHYDRATE
200mg/5ml Anhyd mg/5ml
Powder for Oral Suspension
Product subject to prescription which may not be renewed (A)
Macrolides
Authorised
1992-02-18
Page 1 of 8 2016-0023201 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ZITHROMAX ® POWDER FOR ORAL SUSPENSION 200 MG / 5 ML azithromycin dihydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Zithromax is and what it is used for 2. What you need to know before you take Zithromax 3. How to take Zithromax 4. Possible side effects 5. How to store Zithromax 6. Contents of the pack and other information 1. WHAT ZITHROMAX IS AND WHAT IT IS USED FOR This medicine contains azithromycin, which is one of a group of antibiotics called macrolides. It is used to treat infections caused by certain bacteria and other micro-organisms, which include: chest, throat or nasal infections (such as bronchitis, pneumonia, tonsillitis, sore throat (pharyngitis) and sinusitis ear infections skin and soft tissue infections (such as an abscess or boil) sexually transmitted diseases caused by organisms called chlamydia or gonorrhoea. You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZITHROMAX DO NOT TAKE ZITHROMAX: if you/your child are allergic to azithromycin or any other macrolide antibiotic such as erythromycin or clarithromycin or any of the ingredients listed in section 6. An allergic reaction may cause skin rash or wheezing. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Zithromax if you/your child have or have had any of the following: kidney problems heart conditions diabetes liv Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zithromax Powder for Oral Suspension 200mg/5ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Following reconstitution as directed, each 5 ml of suspension contains 200 mg azithromycin dihydrate. Excipients with known effect Also contains 3.87 g sucrose per 5 ml. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for Oral Suspension. A dry white powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Azithromycin is indicated for the treatment of the following infections when known or likely to be due to one or more susceptible microorganisms (see section 5.1): bronchitis community-acquired pneumonia sinusitis pharyngitis/tonsillitis (see section 4.4 regarding streptococcal infections) otitis media skin and soft tissue infections uncomplicated genital infections due to_ Chlamydia trachomatis_ and_ Neisseria gonorrhoeae._ Considerations should be given to official guidance regarding the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Zithromax should be given as a single daily dose. Zithromax Suspension can be taken with food. CHILDREN OVER 45 KG BODY WEIGHT AND ADULTS, INCLUDING ELDERLY PATIENTS: The total dose of azithromycin is 1500 mg which should be given over three days (500 mg once daily). In uncomplicated genital infections due to_ Chlamydia trachomatis,_ the dose is 1000 mg as a single oral dose. For susceptible_ Neisseria gonorrhoeae_ the recommended dose is 2000 mg azithromycin as a single oral dose together with 500 mg ceftriaxone intramuscularly as a single dose according to local clinical treatment guidelines. For patients who are allergic to penicillin and/or cephalosporins, prescribers should consult local treatment guidelines. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ Read the complete document